Japan’s largest airline, All Nippon Airways (ANA), has extended the suspension of its Narita-Chennai flight operations until March 2027. Industry sources indicate that the decision may be linked to lower occupancy rates.

All Nippon Airways (ANA), Japan’s largest airline, has announced an extension of the suspension of its direct flight route between Narita and Chennai (NH825/NH826) up to March 27, 2027. The update was confirmed in a company release issued on Thursday.

The airline initially suspended operations on this route from March 29 to October 24, 2026. This suspension has now been extended as part of the airline's revised flight schedule for the second half of fiscal year 2026 (FY2026), which outlines broader adjustments to its international flying network.

While the airline detailed its schedule adjustments in the corporate release, sources within the air travel industry have indicated that the ongoing suspension could be attributed to lower passenger occupancy on the route.

The prolonged suspension impacts regular travelers on the corridor. Sankari, a Chennai resident currently living on the outskirts of Tokyo, noted that she now relies on connecting flights through Singapore or Hong Kong to travel to Tokyo. Like other impacted passengers, she expressed hope that the direct service between Narita and Chennai will eventually resume.

"Airlines constantly evaluate route profitability and passenger demand when finalizing their operational schedules. For international carriers, maintaining direct routes requires sustainable occupancy levels. When demand falls short, companies must recalibrate capacity to protect their bottom line, even if it temporarily inconveniences business and leisure travelers on specific corridors." — Dr. Shishir Gupta, Founder & CEO, StartupLanes

Recent StartupLanes Articles

Browse through our 30 latest publications on venture capital, startups, and angel investing.

Kalpataru Projects International Secures New Orders Worth ₹2,349 Crore Oct 22, 2026
MCX Copper Futures Decline From Recent Highs as Market Approaches Key Support Levels Oct 22, 2026
OpenAI Acquires Orchestra Bio to Expand Life Sciences and Drug Development Capabilities Oct 22, 2026
Dr. Reddy’s Laboratories Receives DCGI Approval for Toripalimab in India Oct 22, 2026
Anthropic's Confidential IPO Filing Reveals $80.7 Billion H1 Loss and Heavy Computing Costs Oct 22, 2026
Jio Platforms Launches ₹30,213 Crore IPO: Key Details, Valuations, and Brokerage Views Oct 22, 2026
State Bank of India Reports Suspected Customer Data Exposure on Dark Web Oct 22, 2026
US Secretary of State Marco Rubio Terms Envoy Meeting with Ukrainian President Positive Oct 22, 2026
Rupee Strengthens 29 Paise Against US Dollar in Early Trade, Supported by RBI and Jio IPO Inflows Oct 22, 2026
Brent Crude Stays Above $110 Amid West Asia Supply Concerns and Inventory Data Oct 22, 2026
Indian Market Updates: Corporate Earnings, Strategic Agreements, and Expansion Plans Across Sectors Oct 22, 2026
Corporate Updates: Infosys Expands Truist Collaboration, Cemindia Raises ₹1,400 Crore via QIP, and Multiple Firms Report Contracts and Acquisitions Oct 22, 2026
Centre to Review National Mineral Policy 2019 to Focus on Critical Minerals and Deep-Sea Resources Oct 22, 2026
Qualcomm Announces Global Job Cuts Following Annual Performance Reviews Oct 22, 2026
AstraZeneca Pharma Relocates Registered Office from Karnataka to Maharashtra Oct 22, 2026